close menu

Lorenz Blog

The 20.1 releases of docuBridge, drugTrack and eValidator are available!

Posted on April 30, 2020

The April releases of docuBridge, drugTrack and eValidator are available!

Release Highlights:

What's new in docuBridge? A range of improvements have been made and existing features optimized. Our webAccess module, the web-based version of docuBridge, has been enhanced and offers more features than ever to make your web experience with docuBridge more enjoyable. With our new Regulatory Activity View, assessors and reviewers can focus on the life cycle of a single Regulatory Activity. You can also now track documents and sequences from docuBridge with links to objects in drugTrack. A newly designed interface makes docuBridge's data pools much more accessible. We have also increased the number of personal column layouts that can be created by the user, provided they have personal layouts enabled. In addition to these changes, you can already start using the new draft publishing module for the EUAU and the new Swiss specification (v1.5) are also available. Click here to read more about these highlights: What's new in docuBridge 20.1?

What's new in drugTrack? A number of features will make your work life easier. With the Commitment Tracking extension, you will never miss an important timeline. The Volume Edit of Warnings/Notifications feature lets you save time by checking just a single entry of a volume edit instead of having to approve or reject the same change over and over. Our Package Object offers now a complete overview of your packaging with information on materials, devices, and compositions. Click here to read more about these highlights: What's new in drugTrack 20.1?

What's new in the eValidator? We have made updates and corrections for AU eCTD and Nees, CA eCTD and Non-eCTD, CH eCTD, EU eCTD, GCC eCTD, JO eCTD, TH eCTD, US eCTD, and ZA eCTD.

This entry was posted in LORENZ Solutions and Services.

To stay updated with the latest blog posts and news, follow us on:

© Copyright LORENZ Life Sciences Group. All rights reserved.